AZTA
Azenta, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$33.24
−1.16%Next report
Analyst consensus
- Next report date
- Nov 20, 2026
- EPS estimate
- $0.14
- Revenue estimate
- $160.3M
Latest reported
- Last report date
- Aug 5, 2026
- EPS actual
- $0.16
- EPS estimate
- $0.11
- Revenue actual
- $161.2M
- Revenue estimate
- $149.3M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -26.7%
- Revenue beats (12Q)
- 7
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $36
- PT range
- $35 – $37
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 5, 2026 | $0.11 | $0.16 | Beat 40.60% | $161.2M |
| May 6, 2026 | $0.10 | -$0.04 | Miss -140.00% | $144.8M |
| Feb 4, 2026 | $0.11 | $0.09 | Miss -18.18% | $148.6M |
| Nov 21, 2025 | $0.19 | $0.21 | Beat 10.82% | $159.2M |
| Feb 5, 2025 | $0.05 | $0.08 | Beat 60.00% | $147.5M |
| Feb 7, 2024 | $0.01 | $0.02 | Beat 159.74% | $154.3M |
| Nov 13, 2023 | $0.02 | $0.13 | Beat 629.11% | $172.4M |
| Feb 8, 2023 | $0.06 | $0.12 | Beat 100.00% | $178.4M |
| Nov 14, 2022 | $0.06 | $0.16 | Beat 166.67% | $137.6M |
| Feb 8, 2022 | $0.08 | $0.12 | Beat 50.00% | $139.7M |
| Nov 10, 2021 | $0.77 | $0.78 | Beat 1.30% | $136.9M |
| Aug 5, 2021 | $0.68 | $0.72 | Beat 5.88% | $315.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 20, 2026